ZyVersa Therapeutics Inc.

NASDAQ: ZVSA · Real-Time Price · USD
0.31
-0.24 (-43.53%)
At close: Jul 16, 2025, 3:59 PM

ZyVersa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.41M -98.3M -14.05M -8.08M
Depreciation & Amortization
6.93K 10.4K 9.87K 10.4K
Stock-Based Compensation
705.57K 1.19M 3.52M 4.14M
Other Working Capital
179.31K 194.51K 1.67M -708.45K
Other Non-Cash Items
n/a 95.25M 1.47M 317.83K
Deferred Income Tax
6.75K -9.48M -745.05K -441.58K
Change in Working Capital
929.88K 2.6M 8.29M -1.02M
Operating Cash Flow
-7.56M -8.72M -1.49M -5.08M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -10.7M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -1.46M n/a 5.23M
Financial Cash Flow
5.95M 5.96M 1.87K 5.23M
Net Cash Flow
-1.61M -2.76M 370.74K 153.91K
Free Cash Flow
-7.56M -8.72M -1.49M -5.08M